ENDONOVO THERAPEUTICS, INC.

Endonovo Therapeutics, Inc. is a biotechnology company that creates bioelectronic medical devices for regenerative medicine and post-operative care. Its primary product is SofPulse, a wearable, non-invasive therapeutic device using pulsed electro-magnetic fields to stimulate cellular recovery, accelerate wound healing, and alleviate post-surgical pain and inflammation. The company also investigates bioelectric treatments targeting cardiovascular diseases, chronic kidney disease, and central nervous system disorders. Additionally, it operates a telehealth platform designed to distribute non-opioid pain reduction therapies directly to consumers, and provides commercial medical devices to medical care providers.

The company is headquartered in Woodland Hills, California. It pursues international distribution channels for its flagship therapeutic device across several markets, including Europe, Australia, Southeast Asia, South and Central America, and Taiwan. Endonovo also maintains commercial operations and corporate administration within the United States.

Summary of the business section of Endonovo Therapeutics's latest annual report, written by StockData.